REPORT ID 6914

United States Topical Contraceptive Market Report 2017

Publish Date
1-Nov-17
Pages
116
Format
Electronic (PDF)

In this report, the United States Topical Contraceptive market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Topical Contraceptive in these regions, from 2012 to 2022 (forecast).

United States Topical Contraceptive market competition by top manufacturers/players, with Topical Contraceptive sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Merck Millipore
    Allergan
    Mylan
    Teva Pharmaceuticals
    Janssen Pharmaceutical
    Okamoto Industries
    Reckitt Benckiser
    Syzygy Healthcare
    Agile Therapeutics
    Ansell
    Bayer Pharma
    Caya
    Ferring Pharmaceuticals
    Female Health
    Fuji Latex
    Afaxys
    HLL Lifecare
    Lipocine
    Lupin Pharmaceuticals
    Mayer Laboratories

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Topical Contraceptive Suppository
    Topical Contraceptive Film
    Topical Contraceptive Pill
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Online Stores
    Retail Stores

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Topical Contraceptive Market Report 2017
1 Topical Contraceptive Overview
    1.1 Product Overview and Scope of Topical Contraceptive
    1.2 Classification of Topical Contraceptive by Product Category
        1.2.1 United States Topical Contraceptive Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Topical Contraceptive Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Topical Contraceptive Suppository
        1.2.4 Topical Contraceptive Film
        1.2.5 Topical Contraceptive Pill
        1.2.6 Other
    1.3 United States Topical Contraceptive Market by Application/End Users
        1.3.1 United States Topical Contraceptive Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Online Stores
        1.3.3 Retail Stores
    1.4 United States Topical Contraceptive Market by Region
        1.4.1 United States Topical Contraceptive Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Topical Contraceptive Status and Prospect (2012-2022)
        1.4.3 Southwest Topical Contraceptive Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Topical Contraceptive Status and Prospect (2012-2022)
        1.4.5 New England Topical Contraceptive Status and Prospect (2012-2022)
        1.4.6 The South Topical Contraceptive Status and Prospect (2012-2022)
        1.4.7 The Midwest Topical Contraceptive Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Topical Contraceptive (2012-2022)
        1.5.1 United States Topical Contraceptive Sales and Growth Rate (2012-2022)
        1.5.2 United States Topical Contraceptive Revenue and Growth Rate (2012-2022)

2 United States Topical Contraceptive Market Competition by Players/Suppliers
    2.1 United States Topical Contraceptive Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Topical Contraceptive Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Topical Contraceptive Average Price by Players/Suppliers (2012-2017)
    2.4 United States Topical Contraceptive Market Competitive Situation and Trends
        2.4.1 United States Topical Contraceptive Market Concentration Rate
        2.4.2 United States Topical Contraceptive Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Topical Contraceptive Manufacturing Base Distribution, Sales Area, Product Type

3 United States Topical Contraceptive Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Topical Contraceptive Sales and Market Share by Region (2012-2017)
    3.2 United States Topical Contraceptive Revenue and Market Share by Region (2012-2017)
    3.3 United States Topical Contraceptive Price by Region (2012-2017)

4 United States Topical Contraceptive Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Topical Contraceptive Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Topical Contraceptive Revenue and Market Share by Type (2012-2017)
    4.3 United States Topical Contraceptive Price by Type (2012-2017)
    4.4 United States Topical Contraceptive Sales Growth Rate by Type (2012-2017)

5 United States Topical Contraceptive Sales (Volume) by Application (2012-2017)
    5.1 United States Topical Contraceptive Sales and Market Share by Application (2012-2017)
    5.2 United States Topical Contraceptive Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Topical Contraceptive Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Topical Contraceptive Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Topical Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Merck Millipore
        6.2.2 Topical Contraceptive Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Merck Millipore Topical Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Allergan
        6.3.2 Topical Contraceptive Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Allergan Topical Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Mylan
        6.4.2 Topical Contraceptive Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Mylan Topical Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Teva Pharmaceuticals
        6.5.2 Topical Contraceptive Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Teva Pharmaceuticals Topical Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Janssen Pharmaceutical
        6.6.2 Topical Contraceptive Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Janssen Pharmaceutical Topical Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Okamoto Industries
        6.7.2 Topical Contraceptive Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Okamoto Industries Topical Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Reckitt Benckiser
        6.8.2 Topical Contraceptive Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Reckitt Benckiser Topical Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Syzygy Healthcare
        6.9.2 Topical Contraceptive Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Syzygy Healthcare Topical Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Agile Therapeutics
        6.10.2 Topical Contraceptive Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Agile Therapeutics Topical Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Ansell
    6.12 Bayer Pharma
    6.13 Caya
    6.14 Ferring Pharmaceuticals
    6.15 Female Health
    6.16 Fuji Latex
    6.17 Afaxys
    6.18 HLL Lifecare
    6.19 Lipocine
    6.20 Lupin Pharmaceuticals
    6.21 Mayer Laboratories

7 Topical Contraceptive Manufacturing Cost Analysis
    7.1 Topical Contraceptive Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Topical Contraceptive

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Topical Contraceptive Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Topical Contraceptive Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Topical Contraceptive Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Topical Contraceptive Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Topical Contraceptive Sales Volume Forecast by Type (2017-2022)
    11.3 United States Topical Contraceptive Sales Volume Forecast by Application (2017-2022)
    11.4 United States Topical Contraceptive Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer